| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/02/1997 | US5663179 Can sensitize multidrug resistant cancer cells to chemotherapeutic agents |
| 09/02/1997 | US5663178 5-ht2 receptor antabonists |
| 09/02/1997 | US5663177 Anticarcinogenic agents or antitumor agents |
| 09/02/1997 | US5663174 Antiinflammatory agents, inhibitor of kinases, antiarthritic agents |
| 09/02/1997 | US5663173 Central nervous system disorders, cognition activators, pychoses, antidepressants and eating disorders |
| 09/02/1997 | US5663172 Preventive agent for platelet aggregation |
| 09/02/1997 | US5663171 For use in humans or animals |
| 09/02/1997 | US5663170 Diabetes |
| 09/02/1997 | US5663169 Benzoxazinones as inhibitors of HIV reverse transcriptase |
| 09/02/1997 | US5663167 Antipsychotic composition and method of treatment |
| 09/02/1997 | US5663165 Hypolipidaemic benzothiazepine compounds |
| 09/02/1997 | US5663164 1-dethia-2-thia-cephalosporanic acids |
| 09/02/1997 | US5663161 Anti-viral triaza compounds |
| 09/02/1997 | US5663160 Cosmetic or dermatological composition containing at least one saponin of the ginsenoside type, and its applications, especially for treating the hair |
| 09/02/1997 | US5663159 Prodrugs of phosphonates |
| 09/02/1997 | US5663157 For treating hyperproliferative diseases |
| 09/02/1997 | US5663156 Mixture of higher primary aliphatic alcohols, its obtention from sugar cane wax and its pharmaceutical uses |
| 09/02/1997 | US5663155 Purine nucleoside and deaminase inhibitor |
| 09/02/1997 | US5663154 Viricides, hiv, hepatitis |
| 09/02/1997 | US5663152 Potentiators for aminoglycosides |
| 09/02/1997 | US5663151 Sulfated α-glycolipid derivatives as cell adhesion inhibitors |
| 09/02/1997 | US5663140 Parasiticides for humans and livestock |
| 09/02/1997 | US5663071 An isolated polynucleotide |
| 09/02/1997 | US5663070 Recombinant production of a soluble splice variant of the Fas (Apo-1) antigen, fas TM |
| 09/02/1997 | US5663059 Polynucleotide with code, gene expression |
| 09/02/1997 | US5663053 Inhibition of inflammatory lipid mediators |
| 09/02/1997 | US5662936 Sugar-coated pharmaceutical dosage unit |
| 09/02/1997 | US5662934 Vitamins, gemfibrozil |
| 09/02/1997 | US5662933 Sustained release drugs with gels |
| 09/02/1997 | US5662929 Bactericides using liposomes |
| 09/02/1997 | US5662928 Method for the prevention or removal of crystalline scopolamine in a non-aqueous matrix of a transdermal system |
| 09/02/1997 | US5662927 Sequential adminitration of drugs for estrogen and progesterone and packages |
| 09/02/1997 | US5662923 Self-adhesive |
| 09/02/1997 | US5662922 Iron-containing composition for the prevention of anaemia and a method for producing the composition |
| 09/02/1997 | US5662920 Nicotine lozenge and therapeutic method for smoking cessation |
| 09/02/1997 | US5662918 Bone disorders, storage stable |
| 09/02/1997 | US5662904 Anti-scarring compositions comprising growth factor neutralizing antibodies |
| 09/02/1997 | CA2146151C Method and use of melatonin to induce sleep |
| 09/02/1997 | CA1339422C Crystalline (5r,6s)-2-carbamoyloxymethyl-6-¬(1r)-hydroxyethyl|-2-penem-carboxylic acid and its pharmaceutical formulation |
| 09/02/1997 | CA1339421C Cephalosporin derivatives and processes for their preparation |
| 09/02/1997 | CA1339420C Cefadroxil solvates and method for producing the same |
| 09/02/1997 | CA1339419C Crystalline dihydrochloride of cephalosporin derivative and a method forpreparation thereof |
| 09/02/1997 | CA1339418C Cephalosporin antibiotics |
| 09/01/1997 | CA2198687A1 Quinoxaline derivatives useful in therapy |
| 08/28/1997 | WO1997031119A1 Methods and compositions for protective and therapeutic genetic immunization |
| 08/28/1997 | WO1997031116A2 Recombinant ribonuclease proteins |
| 08/28/1997 | WO1997031115A2 Synthetic hiv genes |
| 08/28/1997 | WO1997031113A1 Cell-based assay |
| 08/28/1997 | WO1997031024A1 Antibody variants |
| 08/28/1997 | WO1997031023A1 Peptide derivatives |
| 08/28/1997 | WO1997031020A1 METHODS AND COMPOSITIONS FOR ENHANCING CELLULAR RESPONSE TO TGF-β LIGANDS |
| 08/28/1997 | WO1997031019A2 Antipathogenic peptides and compositions comprising them |
| 08/28/1997 | WO1997031014A1 Triterpene derivatives and remedies for liver diseases |
| 08/28/1997 | WO1997031013A1 Metabolites of ginseng saponins by human intestinal bacteria and its preparation for an anticancer |
| 08/28/1997 | WO1997031010A1 Receptor protein designated 2f1 |
| 08/28/1997 | WO1997031003A1 Camptothecin derivatives and the use thereof as antitumor agents |
| 08/28/1997 | WO1997031002A1 Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon |
| 08/28/1997 | WO1997031001A1 Possibly substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives |
| 08/28/1997 | WO1997030999A1 Quinolones and their therapeutic use |
| 08/28/1997 | WO1997030998A1 Azabicyclic esters of carbamic acids useful in therapy |
| 08/28/1997 | WO1997030997A1 Tropane-derivatives, their preparation and use |
| 08/28/1997 | WO1997030995A1 Antibiotic oxazolidinone derivatives |
| 08/28/1997 | WO1997030994A1 Oxa- and thia-diazole muscarinic receptor antagonists |
| 08/28/1997 | WO1997030992A1 Inhibitors of farnesyl protein transferase |
| 08/28/1997 | WO1997030990A1 Novel substituted n-methyl-n-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
| 08/28/1997 | WO1997030989A1 Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino)piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
| 08/28/1997 | WO1997030985A1 Benzothiophenes, and formulations and methods, using same |
| 08/28/1997 | WO1997030982A1 2,1,3-benzothia(oxa)diazole derivatives having an endothelin receptor antagonistic effect |
| 08/28/1997 | WO1997030979A1 New antiviral substituted pyrimidinedione homocarbocyclic nucleoside derivatives and methods for the preparation thereof and compositions containing the same as active ingredients |
| 08/28/1997 | WO1997030977A1 Selective d1 dopamine receptor agonists and partial agonists/antagonists |
| 08/28/1997 | WO1997030976A1 Preparation of (s)-decahydroisoquinoline-3-carboxylic acid t-butylamide |
| 08/28/1997 | WO1997030971A1 M-AMIDINO PHENYL ANALOGS AS FACTOR Xa INHIBITORS |
| 08/28/1997 | WO1997030969A1 Pharmaceutical agents containing perfluoroalkyl-containing metal complexes and the use thereof in tumour therapy and interventional radiology |
| 08/28/1997 | WO1997030732A1 Liposomal-viral dna complexes for treating disease |
| 08/28/1997 | WO1997030721A1 Pharmaceutical composition for immunomodulation based on peptides and adjuvants |
| 08/28/1997 | WO1997030720A1 Method of producing an enterosorbent |
| 08/28/1997 | WO1997030716A1 Anti-helicobacter vaccine complex |
| 08/28/1997 | WO1997030714A2 Topical pharmaceutical composition containing heparin |
| 08/28/1997 | WO1997030713A1 Method and composition for inhibiting cellular irreversible changes due to stress |
| 08/28/1997 | WO1997030711A1 External preparation for curing lesioned tissues |
| 08/28/1997 | WO1997030710A1 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| 08/28/1997 | WO1997030709A1 Benzothiophenes, formulations containing same, and methods |
| 08/28/1997 | WO1997030708A1 Pyridinone thrombin inhibitors |
| 08/28/1997 | WO1997030706A1 Composition containing antitumor agent |
| 08/28/1997 | WO1997030705A1 Use of cell membrane permeants in the treatment of cellular proliferative diseases |
| 08/28/1997 | WO1997030704A2 Use of carbonic anhydrase inhibitors for treating macular edema |
| 08/28/1997 | WO1997030703A1 Cerebral function ameliorant containing 1,2-ethanediol derivatives or salts thereof |
| 08/28/1997 | WO1997030702A1 Method of increasing the conversion of homocysteine to methionine and uses thereof |
| 08/28/1997 | WO1997030701A2 Pharmaceutical compositions for the treatment of glaucoma |
| 08/28/1997 | WO1997030699A2 Dosage form of ibuprofen |
| 08/28/1997 | WO1997030698A1 Effervescent ibuprofen preparation and process for the production thereof |
| 08/28/1997 | WO1997030697A1 Method of treating alopecia |
| 08/28/1997 | WO1997030692A1 Cosmetic, dermopharmaceutical or veterinary compositions for disinfecting human or animal skin |
| 08/28/1997 | WO1997030691A1 Skin treatment with salicylic acid esters and retinoids |
| 08/28/1997 | WO1997030690A1 Skin treatment with salicylic acid esters |
| 08/28/1997 | WO1997030677A2 Pentafluorobenzenesulfonamides and analogs |
| 08/28/1997 | WO1997030656A1 Male contraceptive implant |
| 08/28/1997 | WO1997030601A1 Liquid oral compositions comprising a calcium compound and an acidulant |
| 08/28/1997 | WO1997030587A1 Dna vaccination for induction of suppressive t cell response |
| 08/28/1997 | WO1997026523A3 Detection of a leptin receptor variant and methods for regulating obesity |